vulpinic-acid and Atherosclerosis

vulpinic-acid has been researched along with Atherosclerosis* in 1 studies

Other Studies

1 other study(ies) available for vulpinic-acid and Atherosclerosis

Article	Year
Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis. Human & experimental toxicology, 2019, Volume: 38, Issue:6 Vulpinic acid, a lichen compound, has been shown to have many beneficial effects and its medicinal value increases day by day. As in atherosclerosis, endothelial damage is the basis of many diseases. The aim of this study is to investigate the effects of vulpinic acid against oxidative stress damage induced by hydrogen peroxide (H Topics: Antioxidants; Atherosclerosis; Cells, Cultured; Furans; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Lichens; Oxidative Stress; Phenylacetates; Receptor, TIE-2	2019

Article

Year

Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress-related diseases, such as atherosclerosis.

Human & experimental toxicology, 2019, Volume: 38, Issue:6

Vulpinic acid, a lichen compound, has been shown to have many beneficial effects and its medicinal value increases day by day. As in atherosclerosis, endothelial damage is the basis of many diseases. The aim of this study is to investigate the effects of vulpinic acid against oxidative stress damage induced by hydrogen peroxide (H

Topics: Antioxidants; Atherosclerosis; Cells, Cultured; Furans; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Lichens; Oxidative Stress; Phenylacetates; Receptor, TIE-2

2019